Persistence with Cholinesterase Inhibitor Treatment in Alzheimer's Disease

被引：4
|
作者：
Massoud, Fadi [1 ]
机构：
[1] Univ Montreal, Montreal, PQ, Canada
来源：
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES | 2013年 / 40卷 / 05期
关键词：
DEMENTIA; DISCONTINUATION; THERAPY;
D O I：
10.1017/S0317167100014815
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：623 / 624
页数：2
相关论文
共 50 条
  • [31] Cholinesterase Inhibitors Modulate Autonomic Function in Patients with Alzheimer's Disease and Mixed Dementia
    da Costa Dias, Filipi Leles
    Ferreira Lisboa da Silva, Rose Mary
    de Moraes, Edgar Nunes
    Caramelli, Paulo
    CURRENT ALZHEIMER RESEARCH, 2013, 10 (05) : 476 - 481
  • [32] Efficacy of acetyl-cholinesterase-inhibitor (ACHEI) treatment in Alzheimer's disease: A 21-month follow-up "real world" study
    Calabria, Marco
    Geroldi, Cristina
    Lussignoli, Giulia
    Sabbatini, Federica
    Zanetti, Orazio
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2009, 49 (01) : E6 - E11
  • [33] Update on the Pharmacological Treatment of Alzheimer's Disease
    Massoud, Fadi
    Gauthier, Serge
    CURRENT NEUROPHARMACOLOGY, 2010, 8 (01) : 69 - 80
  • [34] Computerized cognition assessment during acetylcholinesterase inhibitor treatment in Alzheimer's disease
    Wesnes, K.
    Edgar, C.
    Andreasen, N.
    Annas, P.
    Basun, H.
    Lannfelt, L.
    Zetterberg, H.
    Blennow, K.
    Minthon, L.
    ACTA NEUROLOGICA SCANDINAVICA, 2010, 122 (04): : 270 - 277
  • [35] Beneficial effect of cholinesterase inhibitor medications on recognition memory performance in mild to moderate Alzheimer's disease: Preliminary findings
    Crowell, TA
    Paramadevan, J
    Abdullah, L
    Mullan, M
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2006, 19 (01) : 13 - 15
  • [36] Cholinesterase Inhibitor Therapy in Alzheimer's Disease: The Limits and Tolerability of Irreversible CNS-Selective Acetylcholinesterase Inhibition in Primates
    Moss, Donald E.
    Perez, Ruth G.
    Kobayashi, Haruo
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 55 (03) : 1285 - 1294
  • [37] Longitudinal Associations between Survival in Alzheimer's Disease and Cholinesterase Inhibitor Use, Progression, and Community-Based Services
    Wattmo, Carina
    Londos, Elisabet
    Minthon, Lennart
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2015, 40 (5-6) : 297 - 310
  • [38] Alzheimer's dementia: budget impact and cost-utility analysis of a combination treatment with a cholinesterase inhibitor and memantine in Switzerland
    Pfeil, Alena M.
    Kressig, Reto W.
    Szucs, Thomas D.
    SWISS MEDICAL WEEKLY, 2012, 142
  • [39] Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer's disease
    Chalmers, Katy A.
    Wilcock, Gordon K.
    Vinters, Harry V.
    Perry, Elaine K.
    Perry, Robert
    Ballard, Clive G.
    Love, Seth
    JOURNAL OF NEUROLOGY, 2009, 256 (05) : 717 - 720
  • [40] A palliative care perspective on deprescribing cholinesterase inhibitors in Alzheimer's disease
    Perri, Giulia-Anna
    Liao, Pamela
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (09) : 1695 - 1697
12345